Informationen:
Fehler:
ID
20209
Beschreibung
Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00905047
Link
https://clinicaltrials.gov/show/NCT00905047
Stichworte
Versionen (1)
- 13.02.17 13.02.17 -
Hochgeladen am
13. Februar 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Colorectal Cancer NCT00905047
Eligibility Colorectal Cancer NCT00905047
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Colorectal Cancer NCT00905047
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Colorectal Carcinoma Advanced Local | Colorectal cancer metastatic
Item
locally advanced or metastatic colo-rectal cancer
boolean
C0009402 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0948380 (UMLS CUI [2])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0948380 (UMLS CUI [2])
Age
Item
age > or = 18 years old
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
ps-who < or = 2
boolean
C1298650 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement
Item
polynuclear neutrophil leukocytes > or = 1500/mm3, platelets > or = 100000/mm3
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0032181 (UMLS CUI [2])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
total bilirubin < or = 3 uln, asat-alat < or = 2.5 uln
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Contraceptive methods
Item
effective contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
written informed consent signed
boolean
C0021430 (UMLS CUI [1])
Therapeutic radiology procedure
Item
concomitant radiotherapy
boolean
C1522449 (UMLS CUI [1])
Medical contraindication fluoropyrimidine
Item
contraindication to fluoropyrimidines
boolean
C1301624 (UMLS CUI [1,1])
C0596581 (UMLS CUI [1,2])
C0596581 (UMLS CUI [1,2])
Sorivudine | Sorivudine Analogs | brivudine
Item
treatment with sorivudine and its chemical analogs such as brivudine
boolean
C0207628 (UMLS CUI [1])
C0207628 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C0163272 (UMLS CUI [3])
C0207628 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C0163272 (UMLS CUI [3])
Hepatic Insufficiency Severe
Item
severe hepatic insufficiency
boolean
C1306571 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Renal Insufficiency Severe
Item
severe renal insufficiency
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating woman
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Hypersensitivity capecitabine | Fluorouracil allergy | Hypersensitivity Tegafur | Hypersensitivity Tegafur Excipient
Item
hypersensitivity to capecitabine, 5fu, tegafur or one of its excipients
boolean
C0020517 (UMLS CUI [1,1])
C0671970 (UMLS CUI [1,2])
C0570698 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0016778 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0016778 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])
C0671970 (UMLS CUI [1,2])
C0570698 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0016778 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0016778 (UMLS CUI [4,2])
C0015237 (UMLS CUI [4,3])